About Us
Myeloma BioBank is dedicated to providing researchers with the highest quality blood and bone marrow samples for multiple myeloma and other plasma cell dyscrasias, including MGUS, amyloidosis, and Waldenstrom’s macroglobulinemia.
Our mission is to accelerate the discovery of new treatments and cures for these diseases through the rapid provision of high quality samples from patients with comprehensive and longitudinal clinical data.
The Institute for Myeloma & Bone Cancer Research (IMBCR) was founded by James R. Berenson, M.D. in 2003
The Berenson Cancer Center is dedicated to the treatment of patients with Multiple Myeloma
Dr. Berenson has published nearly 300 peer-reviewed articles in top scientific and clinical journals
He has recently reported the longest survival rate in the world for patients with Multiple Myeloma*
